Consistent with our previous results, overexpression of RhoGDI2 resulted in increased cell viability compared with control cells (Fig. 6) [33]; however, depletion of Snail expression did not change viability of RhoGDI2-overexpressing gastric cancer cells in response to chemotherapeutic drugs (Fig. 6). The gene discussed is SNAI1; the disease is gastric cancer.